bluuebunny/crossref_metadata_2025_split huggingface dataset:
Preventing vagal response during pulmonary vein isolation with pulsed field ablation: impact of the order of the targeted pulmonary veins
Authors: Del Monte A , Della Rocca D G , Pannone L , Vetta G , Cespon Fernandez M , Doundoulakis I , Marcon L , Monaco C , Bala G , Stroker E , Sieira J , Almorad A , Sarkozy A , Chierchia G B , De Asmundis C 
Published: May 2024

Abstract

Background
Vagal responses are frequently observed during pulmonary vein isolation (PVI). Radiofrequency ablation of the anterior right ganglionated plexus (ARGP) before PVI has been demonstrated to effectively prevent VR occurrence. Pulsed-field ablation (PFA) has emerged as an alternative energy source for PVI. Despite PFA being selective for the myocardium, intraprocedural VRs and reversible effects on ganglionated plexi (GP) have been documented during PVI.

Purpose
We aimed to investigate whether initiating PVI from the right superior pulmonary vein (RSPV) before any other pulmonary veins (PVs) could prevent VR occurrence via concomitant transient ARGP modulation.

Methods
60 consecutive paroxysmal atrial fibrillation patients undergoing PVI with the pentaspline PFA ablation catheter were prospectively included. In the first 30 patients, PVI was started from the left superior pulmonary vein (LSPV-first group). In the last 30 patients, the RSPV was targeted first, followed by the left PVs, and finally the right inferior PV (RSPV-first group). VR was defined as sinus bradycardia (&lt;40 beats/min), asystole, or atrioventricular block (AVB). Heart rate (HR) was evaluated at baseline, during PVI, and post-ablation to assess GP modulation.

Results
Baseline characteristics were similar between the two study groups. VR during PVI occurred in 22 (73%) patients in the LSPV-first group and 3 (10%) in the RSPV-first group (Figure1, p&lt;0.001). A higher rate of VRs was observed in patients in the LSPV-first group compared to patients in the RSPV-first group during ablation of the LSPV and LIPV (73% vs. 7%, p&lt;0.001 and 27% vs. 0%, p=0.005, respectively), while no differences were found during ablation of the right PVs. Temporary pacing was employed in 10 (33%) patients in the LSPV-first group and 3 (10%) in the RSPV-first group (p=0.028). RSPV isolation induced similar acute HR increase in the two groups (13±9 bpm vs 13±10 bpm, p=0.9). However, no significant HR variation was documented in both groups at the end of the procedure compared to baseline (all p&gt;0.05).

Conclusion
PVI with PFA is frequently associated with intraprocedural VRs when ablation is initiated from the LSPV. However, an RSPV-first approach determined transient HR increase and reduced VR occurrence.Figure 1
Functional substrate mapping characteristics during sinus rhythm predicts critical isthmus of scar related atrial tachycardia
Authors: Yorgun H , Coteli C , Kilic S , Aytemir K 
Published: May 2024

Abstract

Background
Atrial tachycardia (AT) is a common rhythm disorder in patients with underlying atrial scar due to previous atrial surgery or valvular heart disease. Data is scarce about the role of functional characteristics or conduction properties during sinus rhythm that may have role in the critical isthmus (CI) of re-entry.

Purpose
We aimed to evaluate the relationship between the functional substrate mapping (FSM) characteristics of right and left atrium and the CI of re-entrant ATs in patients with atrial low-voltage areas.

Methods
A total of 95 [mean age: 57 ± 13, gender: 57 (60%) female] symptomatic patients with history of left and right AT who underwent catheter ablation with 3-D high-density mapping were enrolled. Isochronal late activation mapping were created during sinus/paced rhythm to detect deceleration zones (DZ). After induction of AT, activation mapping was performed in all patients.

Results
In 95 patients, 96 left-ATs [49 (51%) ATs were macroreentry and 47 (49%) ATs were localized reentry] and 40 right-ATs [24 (60%) ATs were macroreentry and 16 (40%) ATs were localized reentry] were mapped. Atrial low voltage zones comprised 23.3 ± 13.0 % of total right atrium and 33.3 ± 21.2 % of total left atrium. The mean value of bipolar voltage, EGM duration, and conduction velocity during sinus rhythm corresponding to CI of ATs were 0.17 ± 0.10 mV, 121 ± 39 ms, and 0.09 ± 0.06 m/s, respectively. Total number of DZs were 125 and all CIs of reentry were colocalized with DZs detected during FSM. The positive predictive value of DZs to detect CI of inducible ATs is 87.2%. Freedom from ATa was 76.8% at 12 months follow-up.

Conclusion
Our findings demonstrated the utility of FSM during sinus rhythm to predict the successful termination sites for ATs. These areas displayed continuous-fragmented signal morphology in correlation with the CI of AT detected during activation mapping.
Differentiation of high frequency near field versus far-field potentials in low voltage zones during sinus rhythm improves discrimination of local sites of termination during ventricular tachycardia
Authors: Merino Fuentes D , Handayani A , Castrejon Castrejon S , Guido Lopez L , Martinez Cossiani M , Jauregui Abularach M , Sanchez Somonte P , Martinez Maldonado M E , Sanz Verdejo B , Merino Llorens J L 
Published: May 2024

Abstract

Background
Ventricular tachycardia (VT) with structural heart disease (SHD) is often bad tolerated or presents with several inducible morphologies, this support mapping the arrhythmic substrate during sinus rhythm (SR). Poor discrimination between near-field (NF) and far-field (FF) electrogram (EGM) components in low voltage (LV) areas is the main limitation. The peak frequency (PF) associated with bipolar EGMs may distinguish NF from FF EGMs (Panel D).

Objective
To evaluate if PF combined with voltage mapping during SR enhances discrimination of the region of VT termination by radiofrequency application (RFa).

Methods
Bipolar activation and voltage maps were generated with a 16-pole grid catheter (HD Grid) during SR (Panel B). PF maps were retrospectively computed (Panel C). The maps were only analyzed if acute termination was achieved by focal RFa within a boundary diameter &lt;1.5cm (Panel A). The mapped surface area (SA) was sub-regioned in termination (T-ZONE) and non-termination (NT-ZONE) zones. The T-ZONE surface was centered about the termination site and was allowed to extend to a rectangular kernel &gt;0.5cm and &lt;1.5cm across perpendicular axes, with the NT-ZONE encompassing the remainder mapped SA. Sensitivity (SE) and specificity (SP) of discrimination of the T-ZONE vs. NT-ZONE were measured according to the %SA covered at different LV thresholds (0.1-1.0mV in increments of 0.1mV - Panel F). LV high PF (LVHF) areas at different PF cutoffs from 150Hz (LVHF150) to 300Hz (LVHF300) were also assessed.

Results
15 patients with SHD and sustained monomorphic VT were enrolled. 4 had 5 VT’s terminated by 1.4±0.9 focal RF lesions (60-74 y/o, 3 ischemic). All termination sites were located in a LVHF region mapped during SR (Panels B,C,E). The T-ZONE occupied 0.41±0.33cm /92.75±13.31cm global SA and consisted of 15±10 EGM points/1432±337 global points. T-ZONE voltage during SR (0.50±0.32mV) was significantly lower vs. global voltage (2.01±0.69mV, P&lt;0.001), while T-ZONE PF was higher (324±51Hz) vs. global (270±37Hz, P&lt;0.001). ROC discrimination of the T-ZONE yielded AUC’s of 0.79-LV alone, 0.87- LVHF150, 0.91-LVHF200 (Delta +12.2% vs LV alone, Panel F), 0.85-LVHF250 and 0.77-LVHF300. At a 0.7mV cutoff, LVHF200 yielded a balanced SE/SP of 0.89/0.87 vs. LV alone (0.90/0.63).

Conclusion
Assessment of regions with LVHF during SR improves SP for discrimination of sites of VT termination compared to LV alone.TV near field
Local impedance drop as a predictor of sucessful pulmonary vein isolation
Authors: Montilla Padilla I , Alfonso Almazan J M , Marin Garcia I , Lopez Rodriguez G , Ramos Maqueda J 
Published: May 2024

Abstract

1. Introduction
Pulmonary vein isolation (PVI) is the cornerstone of AF treatment. An accurate estimation of the lesion size and a optimal evaluation of the catheter-myocardium coupling is crucial for achieving an effective and safe radiofrequency (RF) ablation. A few studies have suggested that local impedance (LI) drop is a better predictor than general impedance drop in terms of lesion size, electrical coupling and therefore acute PVI success. An open-irrigated ablation catheter designed to measure contact force (CF) and LI drop while applying RF has been recently developed.

2. Purpose
The aim of this study is to evaluate if conduction GAPS are located in certain areas and if LI drop can predict the presence of conduction gaps in each of these segments.

3. Methods
Observational prospective study including 55 consecutive patients who underwent PVI. The RF lesions were delivered with 30 W (posterior wall) or 35 W (anterior wall) for a maximum of 30 seg with a CF &gt; 5 g. The applications were stopped if a LI of 35 Ohm was reached on the posterior wall or 40 Ohm on the anterior wall.
PVs were divided into seven segments and ablation tags were assigned to a segment according to their anatomical position (figure 1) We categorized the tags included in each segment as successful or not according to the presence of conduction gaps detected with an Ultrahigh density mapping catheter once the WACA was completed. At the same time lesion by lesion were studied regardless of the segment where it was located.

4. Results
We analyzed 4002 lesion tags of 55 patients who underwent PVI. 53 Gaps were found in 19/55 (34.5%) left WACA and 16/54 (29,6%) right WACA and were localized predominantly in three PVI segments (L1, L6 and R3) 34(54.85%) vs 19 (35,8%) (L2-L5, L7, R1-R2, R4-R7) (p&lt;0.001) (figure 1). They were mainly circumscribed to anterior segments in left PVs and posterior-superior segment in right PVs (figure1).
When examining lesions independently of their location we found a significant difference in LI drop among successful and unsuccessful lesions (24.22±8.31 vs 15.67±7.85) Ohm, p&lt;0.001).
In the same line when studying lesions in those segments with &gt; 10% of GAPS (L1, L6 R1 and R3) LI drop was greater in successful lesion tags: L1 25.2 ± 5.35 vs 16.8 ± 5.17 (p&lt;0.001), L6 25.2±5.7 vs 16±5.48 (p&lt;0.001), R1 27.9±4.78 vs 17.1±5.73 (p=0.03) and R3 18.5±5.4 vs 10.7±2.49 (p&lt;0.001).

5. Conclusions
Gaps were located predominantly in anterior segments in left PVs and posterior-superior segment in right PVs. A low LI drop was an excellent predictor of conduction gaps, and it performs well regardless of the segment where it was analyzedFig. 1
Implementation of near zero fluoroscopy in supraventricular tachycardia ablation procedures: a single center experience
Authors: Lebreiro A , Pestana G , Madeira M , Alves Pinto R , Pinto R , Araujo P , Martins C , Adao L 
Published: May 2024

Abstract

Background
Supraventricular tachycardia (SVT) are common cardiac arrhythmias, and catheter ablation has proven to be a very effective treatment, but exposes patients and healthcare providers to radiation. "Near Zero Fluoroscopy" (NZF) techniques, utilizing advanced imaging, aim to reduce radiation exposure while maintaining efficacy.

Purpose
To present an analysis of near-zero fluoroscopy in SVT ablation procedures, in a tertiary center, since its implementation.

Methods
We prospectively enrolled 446 SVT-diagnosed patients for this study. All of them underwent NZF procedures using the same specific 3D mapping system, between January/19 and December/22. Patients with atrial fibrillation or macroreentrant atrial tachycardias or when a different mapping system was used, were excluded. All patients provided informed consent.

Results
Our population had 266 (60%) females and a median age of 39 (IQR 24-51) years.
AVNRT was the most frequent arrhythmia documented (229 cases, 51%), followed by Accessory Pathways (AP) (201 cases, 45%) and focal atrial tachycardia (AT) (16 cases, 4%). The ablation success rate was high (405/418, 97%). There was no ablation attempt in 12 patients (9 APs and 3 ATs) and the unsuccessful ablations (7/418 cases, 1,67%) were APs. Overall, fluoroscopy time was 1.1 minutes (IQR 0-2.6). There was no statistically significant difference in the distribution of fluoroscopy time among the types of SVT based on the Kruskal-Wallis test (p 0.14).
Observing trends of fluoroscopy use through time, we acknowledge the presence of a learning curve, leading towards shorter times of X-ray during procedures along the first 3 years of implementation of a near-zero strategy. Median times (IQR) of fluoroscopy were as follows: 2019 – 2.25 (0.45-3.4) min; 2020 – 1 (0-2.5) min; 2021 – 0 (0-1.9) min; 2022 – 0.55 (03.05) min. (see BoxPlot) Pairwise comparisons using the Wilcoxon rank-sum test with continuity correction revealed statistically significant differences in medians between all pairs of years, with p-values adjusted for multiple comparisons using the Bonferroni method (p&lt;0.01). In 2022, fluoroscopy time increased, when compared to 2021. We believe this finding can be explained by the fact that in 2022, our department received a new fellow and a young EP consultant (coming from a center where NZF was not the standard for SVT ablation), both being in the lab on a daily basis, explaining this upward trend in fluoroscopy time.
There were no acute complications requiring hospital admission or active treatment.

Conclusion
Our results emphasize the potential of near-zero fluoroscopy techniques to enhance safety and reduce radiation exposure while maintaining a high level of procedural efficacy in the treatment of SVT cases. Absence of acute complications highlighted the safety of these approaches.
Activation map of koch triangle: a novel approach to AVNRT ablation using CARTO 3 v7
Authors: Chieffo E , Carrozzi C , Cacucci M , D'amore S , Dossena C , Landolina M E 
Published: May 2024

Abstract

Background
Ablation of slow pathway (SP) is the standard approach for atrioventricular nodal reentry tachycardia (AVNRT) treatment (1). Low-voltage bridge is an optimal target during mapping using low x-ray exposure (2,3).

Purpose
We want to assess a new tool to identify SP by activation mapping of Koch’s triangle using CARTO PRIME V7

Methods
Triangle of Koch 3D-activation map were obtained from intracardiac contact mapping during low x-ray CARTO 3 procedures (Figure 1). In 60 patients (39 % males, mean age 60.3 ± 14.7 years) undergoing ablation for AVNRT, an automatic activation map using a DECANAV mapping catheter and CARTO Confidense, Coherent, and FAM DX software modules were obtained.

Results
We indentified SP in all patients as the latest atrioventricular node activation area; RF catheter ablation (RFCA) elicited junctional beats. The mean dose-area product (DAP) was 16.5 ± 2.7 cGy/cm2, the mean fluoroscopy time exposure was 2.9 ± 2 min, the mean ablation index was 428.6 ± 96.6, and the mean contact force was 8 ± 2.8 g. There were no adverse event during the procedure and no AVNRT recurrences during a mean follow-up of 14.3 ± 8.3 months.

Conclusions
Ablation of the SP by automatic mapping using Confidense, Coherent, and FAM DX software modules is a new approach to AVNRT ablation. The CARTO3 V7 system defines a 3D map of the latest AV node activation area during sinus rhythm allowing a highly effective RFCA under low fluoroscopy time exposure without recurrences or AV blocks.Figure 1
The challenge of transseptal access for catheter ablation of left-sided arrhythmia substrate in infants and small children under 6 years of age
Authors: Nagy Z , Szabo A , Csakany L , Major T , Som Z , Foldesi C , Kornyei L 
Published: May 2024

Abstract

Background
Young age and small cardiac dimensions are increased risk factors for catheter ablation (CA), therefore ablation below 15 kg should be recommended only in selected drug-refractory cases. The need for a transseptal puncture (TSP) may be an additional risk factor. Persistent foramen ovale (PFO) in infants can mitigate this risk and paradoxically, decrease the complication rate in the very young.

Purpose
This study aimed to compare the results of left-sided CA in infants under 1 year and in children between 1-6 years of age.

Methods
Between January 2010 and September 2023, 1703 pediatric CAs were performed, of which 17 left-sided ablations in children under 6 years without structural heart disease were retrospectively evaluated. CA results below 1 year and between 1-6 years of age were compared in terms of body size, procedural parameters, left atrial (LA) access, complication, and success rate.

Results
The patient group below 1 year (Group 1, n=5) has a mean age=0.13±0.03 years, mean body weight=3.6±1.1 kg, mean height=52.3±3.6 cm. Patients between 1-6 years (Group 2, n=12) have mean age=5.0±1.1 years, mean body weight=17.9±2.2 kg, mean height=111.2±7.4 cm. The arrhythmia substrate was an overt pathway in 3 pts (17.6%), concealed accessory pathway in 7 pts (41.2%), and focal LA tachycardia in 7 pts (41.2%). Foramen ovale was persistent in all 5 children in Group 1 and TSP was not required. In Group 2, only 2 pts (16.7%) had PFO, and, all other procedures required TSP. TSP was successful in 9/10 cases (90%). No complications related to LA access or other adverse events occurred in Group 1. In Group 2, there was one case of pericardial effusion that spontaneously regressed and one case of mechanical-induced advanced AV block that resolved after six days. There were no significant differences in procedure time, fluoroscopic time, and radiation dose between the two groups (Group 1: 126.4±47.0 min, 6.4±4.5 min, 4.0±5.3 cGycm2 vs. Group 2: 162.6±49.2 min, 7.9±9.4 min, 9.0±12.4 cGycm2, p&gt;0.05). All CAs were performed with RF energy. The acute success rate of the procedures was 100%.

Conclusion
CA of left-sided arrhythmias in infants and small children may offer a safe and effective therapeutic option in selected cases. The high prevalence of PFO may explain the paradoxically less complication under 1 year of age.
Safety and efficacy outcomes in 100 consecutive cases of pulsed field ablation
Authors: Murray P , O'hare D 
Published: May 2024

Abstract

Background
Pulsed field ablation (PFA) an emerging technology for ablation of atrial fibrillation (AF). This non-thermal ablation modality uses ultrarapid electrical pulses to destabilise cell membranes and can selectively ablate myocardial tissue. Successful pulmonary vein isolation (PVI) and reductions in procedure times compared to other modalities have been observed in initial studies.

Aim
To report initial outcomes and fluoroscopic times in the first 100 consecutive cases using PFA in AF ablation.

Methods
The first 100 consecutive PFA cases carried out by a single operator in a single centre were examined. All cases were performed under general anaesthesia, using ultrasound-guided vascular access and TOE-guided transseptal puncture. Outcomes were recorded from the first case in June 2022 to the present day. Electroanatomic mapping (EAM) was carried out using two proprietary systems.

Results
Procedural information and follow-up was achieved in all 100 patients (see table). The majority (77) were male. Mean age 61. Cardiovascular comorbidities included: hypertension (41), heart failure (12), ischaemic heart disease (10), stroke (4), diabetes mellitus (3). Antiarrhythmic drugs were used by 45 patients (Amiodarone in 22, Dronedarone in 18, Flecainide in 10, Sotalol in 8, Mexiletine in 1) with 55 taking beta blockers only or no rhythm control drugs. Persistent AF accounted for 57 cases, and 91 patients had no prior ablation procedure.
Median CHA2DS2VASC 1. Warfarin was used on 1 patient, the other 99 patients underwent ablation on uninterrupted DOAC, most commonly Apixaban. EAM was conducted in 59 patients. Stand-alone PVI was carried out in 68, while 30 underwent an additional posterior wall box isolation, and a mitral isthmus line was added in a further 2 who had atrial flutter (AFl) during the procedure following successful PVI.
There were no serious peri-procedural complications. (vascular access complications, pericardial effusion, stroke or death). All 100 patients were discharged following a one-night stay. Clinical pericarditis without effusion occurred in 1 patient on day 2, and resolved with a short course of Colchicine.
Mean fluoroscopy time was 9minutes, 12seconds, and reductions in fluoroscopy times correlated significantly with case number (see figure). Mean fluoroscopy time was 2mins, 30secs higher where EAM was used. Sinus rhythm was achieved in 100%. Atrial arrhythmia recurred in 12 patients, 7 with AF and 3 atrial flutter, 2 with typical symptoms which could not be documented. Two of the recurrences were within 24 hours of the procedure.

Conclusions
This registry data shows that PFA was used to achieve PVI safely, with effective additional substrate ablation also demonstrated. There were no serious peri-procedural complications, and procedural improvements in fluoroscopic times were observed throughout the 100 cases. Long term follow-up data is required to validate the safety and efficacy of this new technology.
Focal pulsed field ablation for organised atrial tachyarrhythmias: one to rule them all
Authors: Sikiric I , Jurisic Z , Breskovic T , Lisica L , Dagelic M , Katic J , Anic A 
Published: May 2024

Abstract

Background
Focal pulsed field ablation (fPFA) has emerged as a versatile and innovative strategy for ablating atrial tachyarrhythmias (1). The primary objective of this study is to present the short-term safety characteristics, feasibility and procedural outcomes of fPFA in the management of organised atrial tachyarrhythmias. This report focuses on the commercial use of an innovative pulsed field ablation (PFA) generator, utilized in conjunction with commercially available focal, solid-tip ablation catheters, and complemented by 3D electro-anatomical mapping (3D-EAM).

Methods
Patients with organised atrial tachycardia treated using fPFA between August 2022 and September 2023 at our center were included in this retrospective analysis. Tachycardia mechanisms were identified with high-definition, multi-electrode mapping catheter paired with 3D-EAM system. Ablation lines, when targeting macro-reentrant arrhythmias were strategicaly positioned to adress critical isthmi when recognised or they were empirically placed between the anatomical obstacles ( including LA roof, anterior, mitral isthmus, upper septal and cavotricuspid line as deemed appropriate). Positioning of the fPFA catheter was guided by 3D-EAM, intracardiac ultrasound, and fluoroscopy (Figure 1). Bidirectional block verification was performed using standard criteria to assess acute procedural success. Glyceryl trinitrate boluses were administered prior to ablation in proximity to coronary arteries.

Results
In a cohort of 36 patients (median age 62 years; 12 females), we effectively mapped and treated a total of 51 distinct organised atrial tachyarrhythmias. These included 18 typical flutters, 3 roof-dependent macro-reentries, 4 posterior-wall micro-reentries, 15 peri-mitral macro-reentries, 8 anterior-wall micro-reentries and 3 biatrial macro-reentries via Bachman bundle. Our ablation strategy involved creating 21 cavotricuspid isthmus lines, 3 roof lines, 18 posterior wall lines, 11 anterior lines, 8 septal lines, and 15 mitral isthmus lines (Figure 2). Impressively, first-pass acute isolation with bidirectional block was achieved in 93% (54 of 58) of isthmus ablations and 94% (17 of 18) of left posterior wall lines. No ST segment alterations or other complications were observed during the periprocedural period.

Conclusion
In our cohort fPFA proved as a feasible, effective, and safe approach for treating organised atrial tacharrhythmias. The primary reason for designating this setup as our preferred choice for redo procedures lies in its versatility in addressing a wide range of arrhythmias. As ultra-fast pulmonary vein isolation (PVI) procedures become more prevalent with the expansion of PFA, the demand for an ideal setup capable of effectively targeting various substrates will become even more pronounced (2). Notably, our findings suggest superior suitability and efficacy when compared to bulkier, single-shot design PFA devices (3).Figure 1Figure 2